Heng Fai Ambrose Chan, Director at IMPACT BIOMEDICAL INC. (IBO), sold 703,110 shares at $0.50 ($352K) on 2025-04-03, disclosed to the SEC on 2025-04-07.
Open-market sale of $352k IBO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.50 | 351,555 | $176K | 50.0% |
| 2 | $0.50 | 351,555 | $176K | 50.0% |
| Total | $0.50 avg | 703,110 | $352K | 100% |
| Filing → |
| AEI | SELL | 2025-09-16 | $1.3M | — | Filing → |
| DSS | SELL | 2025-09-02 | $176K | — | Filing → |
| AEI | BUY | 2025-08-19 | $43K | — | Filing → |